Medicared For All Logo

Muhammad-ali Zaydan MD in Mt Sterling, Kentucky

Home Kentucky Mt Sterling

Muhammad-ali Zaydan MD has Hematology/oncology as his primary medical specialty. Their primary office is: 644 Maysville Rd in Mt Sterling, Kentucky. There is an additional office location, for a total of two, for Muhammad-ali Zaydan MD that can be viewed further down. They attended Sorry, his university is not listed and graduated in 1991 (around 33 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Muhammad-ali A Zaydan MD Office Phone and Directions

Muhammad-ali Zaydan MD
644 Maysville Rd
Mt Sterling, Kentucky 40353
859-499-1000


Patient Ratings
Please rate your experience with Muhammad-ali Zaydan MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 859-499-1000


Enter a starting address:


Healthcare Info for Muhammad-ali Zaydan MD

Medical School: Sorry, his university is not listed
Graduation Year: 1991
The Primary Medical Specialty for Muhammad-ali Zaydan MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 8224026612
NPI #: 1750350633
NPI Created On: 03/14/2006
NPI Last Updated Listed as: 03/04/2014
Primary Taxonomy Code: 207RH0003X
License Number:
37117
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • CareSource
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Portuguese, Arabic, Arabic/Jordanian.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Nuclear medicine study with ct imaging whole body
  3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  4. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
  5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  6. Infusion of chemotherapy into a vein up to 1 hour
  7. New patient office or other outpatient visit, typically 60 minutes
  8. Established patient office or other outpatient visit, typically 15 minutes
  9. Established patient office or other outpatient, visit typically 25 minutes
  10. Initial hospital inpatient care, typically 70 minutes per day
  11. Smoking and tobacco use intensive counseling, greater than 10 minutes
  12. Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
  13. Injection, diphenhydramine hcl, up to 50 mg
  14. Injection, methylprednisolone sodium succinate, up to 125 mg
  15. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
  16. Infusion, normal saline solution, sterile (500 ml = 1 unit)
  17. Infusion, normal saline solution, 250 cc

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788638395

Being Disputed:: No

Product Related: No


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788638397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788638399

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788638401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016491

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818654909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818667647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818667649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818672159

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $125

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 802579075

Being Disputed:: No

Product Related: No


Additional Office Locations

1.
920 Elizaville Ave
Flemingsburg, KY 41041
Group Members: 0

Phone: 859-499-1000

Enter a starting address:


Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry